Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-cash Items (2019 - 2023)

Historic Non-cash Items for Korro Bio (KRRO) over the last 5 years, with Q3 2023 value amounting to $9.5 million.

  • Korro Bio's Non-cash Items rose 79104.62% to $9.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.5 million, marking a year-over-year increase of 79104.62%. This contributed to the annual value of $19.5 million for FY2022, which is 5004.86% down from last year.
  • According to the latest figures from Q3 2023, Korro Bio's Non-cash Items is $9.5 million, which was up 79104.62% from $12.5 million recorded in Q2 2023.
  • In the past 5 years, Korro Bio's Non-cash Items registered a high of $55.4 million during Q1 2021, and its lowest value of $789000.0 during Q2 2022.
  • In the last 5 years, Korro Bio's Non-cash Items had a median value of $17.6 million in 2023 and averaged $19.6 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first plummeted by 9768.53% in 2022, then surged by 148884.66% in 2023.
  • Korro Bio's Non-cash Items (Quarter) stood at $13.8 million in 2019, then surged by 124.36% to $31.0 million in 2020, then increased by 26.14% to $39.1 million in 2021, then crashed by 50.05% to $19.5 million in 2022, then crashed by 51.61% to $9.5 million in 2023.
  • Its Non-cash Items stands at $9.5 million for Q3 2023, versus $12.5 million for Q2 2023 and $17.6 million for Q1 2023.